Literature DB >> 14991599

Demonstration of strong enterobacterial reactivity of CD4+CD25- T cells from conventional and germ-free mice which is counter-regulated by CD4+CD25+ T cells.

Monika Gad1, Anders Elm Pedersen1, Nanna N Kristensen1, Mogens H Claesson1.   

Abstract

Unfractionated CD4+ T cells from the gut-associated lymphoid tissue (GALT) and peripheral lymph nodes are unresponsive when exposed to enterobacterial antigens in vitro. Under similar conditions, CD4+ T cells depleted in vivo or in vitro of CD4+CD25+ T cells proliferate extensively. The CD4+CD25- T cell reactivity depends on MHC class II presentation, specific TCR stimulation, CD4 ligation, and antigen processing by antigen-presenting cells. The CD4+CD25- T cells respond to autologous and heterologous enterobacterial antigens, but not to antigens from the feces of germ-free mice. Surprisingly, CD4+CD25- T cells obtained from the GALT of germ-free mice also proliferate when exposed to enterobacterial antigens, and adding back the conventional or germ-free CD4+CD25+ T cells to the enteroantigen-stimulated CD4+CD25- T cells abolishes proliferation. As judged from carboxyfluorescein diacetate succinimidyl ester-labeling experiments, 4-5% of the CD4+CD25- T cells respond to enteroantigen. The data show for the first time that CD4+CD25- T cells with reactivity towards the enterobacterial flora and regulatory CD4+CD25- T cells are present in both conventional and germ-free mice. The data suggest that a significant proportion of the peripheral pool of CD4+CD25- T cells express anti-enterobacterial reactivity, which, due to the presence of regulatory CD4+CD25+ T cells, is kept in a quiescent state.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14991599     DOI: 10.1002/eji.200324394

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  8 in total

1.  T cell-mediated oral tolerance is intact in germ-free mice.

Authors:  K L W Walton; J A Galanko; R Balfour Sartor; N C Fisher
Journal:  Clin Exp Immunol       Date:  2006-03       Impact factor: 4.330

2.  Commensal microbiota drive proliferation of conventional and Foxp3(+) regulatory CD4(+) T cells in mesenteric lymph nodes and Peyer's patches.

Authors:  Sascha Cording; Diana Fleissner; Markus M Heimesaat; Stefan Bereswill; Christoph Loddenkemper; Satoshi Uematsu; Shizuo Akira; Alf Hamann; Jochen Huehn
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2013-03-13

Review 3.  Regulatory T cells in experimental autoimmune disease.

Authors:  Elisabeth Suri-Payer; Benedikt Fritzsching
Journal:  Springer Semin Immunopathol       Date:  2006-07-13

4.  Role of LFA-1 in the activation and trafficking of T cells: implications in the induction of chronic colitis.

Authors:  Iurii Koboziev; Fridrik Karlsson; Dmitry V Ostanin; Laura Gray; Melissa Davidson; Songlin Zhang; Matthew B Grisham
Journal:  Inflamm Bowel Dis       Date:  2012-04-05       Impact factor: 5.325

5.  Characterization of T-regulatory cells, induced by immature dendritic cells, which inhibit enteroantigen-reactive colitis-inducing T-cell responses in vitro and in vivo.

Authors:  Monika Gad; Nanna N Kristensen; Evelyn Kury; Mogens H Claesson
Journal:  Immunology       Date:  2004-12       Impact factor: 7.397

6.  More Active Intestinal Immunity Developed by Obese Mice Than Non-Obese Mice After Challenged by Escherichia coli.

Authors:  Dongjie Cai; Bin Tian; Shuang Liang; Yao Cen; Jing Fang; Xiaoping Ma; Zhijun Zhong; Zhihua Ren; Liuhong Shen; Liping Gou; Ya Wang; Zhicai Zuo
Journal:  Front Vet Sci       Date:  2022-06-03

7.  Tolerogenic dendritic cells pulsed with enterobacterial extract suppress development of colitis in the severe combined immunodeficiency transfer model.

Authors:  A E Pedersen; M Gad; N N Kristensen; C Haase; C H Nielsen; M H Claesson
Journal:  Immunology       Date:  2007-04-12       Impact factor: 7.397

8.  Gut microbiota and lipopolysaccharide content of the diet influence development of regulatory T cells: studies in germ-free mice.

Authors:  Tomas Hrncir; Renata Stepankova; Hana Kozakova; Tomas Hudcovic; Helena Tlaskalova-Hogenova
Journal:  BMC Immunol       Date:  2008-11-06       Impact factor: 3.615

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.